Viewing nowCombinationZadiglimmet Tablets 5/1000 mg (Empagliflozin 2L-Proline, Metformin)
Empagliflozin 2L-Proline 7.56mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.

MFDS item code 202503039 · Approved 2025.11.21
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication helps adults with type 2 diabetes effectively control their blood sugar when used in conjunction with empagliflozin and metformin. It is particularly administered as an adjunct therapy for patients following dietary and exercise regimens. It is used when blood sugar is not sufficiently controlled and is also suitable for patients with cardiovascular diseases, but caution is required based on professional clinical trial information. Therefore, this medication is useful for controlling blood sugar in patients with type 2 diabetes and preventing cardiovascular diseases.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients who take this medicine because adequate glycemic control cannot be achieved with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and their current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with empagliflozin and metformin as separate individual medicines. The maximum daily dose of metformin hydrochloride that can be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately. In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication is used for the treatment of diabetes and aids in regulating blood sugar levels. This medication should not be used in patients with impaired kidney function or those with acute infections, dehydration, or severe heart conditions. It is also recommended that pregnant or breastfeeding women avoid this medication for safety. Caution is warranted when taking this medication as hypoglycemic symptoms might occur, particularly when used with insulin or other hypoglycemic agents. A rare side effect, severe lactic acidosis, may occur, which can be life-threatening; immediate consultation with a doctor is required if symptoms present. This medication may increase the risk of urinary or genital infections, so immediate treatment should be sought if infectious symptoms occur. Regular monitoring of kidney function and blood sugar status is recommended during treatment, and checking of vitamin B12 levels is also advisable. Before surgery or diagnostic tests involving contrast agents, this medication may need to be discontinued for a specific period, and its resumption should be based on confirmation of normal kidney function. During treatment, caution should be exercised against dehydration or fluid loss, and medical personnel should be informed immediately of any dehydration symptoms. Alcohol consumption should be avoided as it may increase the risk of side effects associated with this medication. Elderly patients or those with impaired kidney function should take this medication with special care, and dosage adjustments may be required. In case of overdose, appropriate medical treatment should be sought immediately, and blood dialysis may be necessary. This medication is not recommended for children as its safety and efficacy have not been established. If any unusual symptoms or discomfort occur during treatment, immediately consult a doctor or pharmacist.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius.
Biconvex oval film-coated tablet with a yellow color with a brownish tint
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 2L-Proline 7.56mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.9mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Mothers Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.55mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.55mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyeongbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 7.55mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 2L-Proline 18.88mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.